Cervical Cancer News and Research RSS Feed - Cervical Cancer News and Research

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.
IMRT reduces risk of side effects, improves quality of life for endometrial and cervical cancer patients

IMRT reduces risk of side effects, improves quality of life for endometrial and cervical cancer patients

Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience better quality of life when treated with intensity-modulated radiation therapy (IMRT) than with conventional radiation therapy (RT), according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology. [More]
Researchers underscore importance of immune-based prevention to conquer cancer

Researchers underscore importance of immune-based prevention to conquer cancer

In a Perspective piece published this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, write that a greater emphasis on immune-based prevention should be central to new efforts like the federal Cancer Moonshot program, headed by Vice President Joe Biden. [More]
Americans believe cancer to be major health care challenge, Mayo Clinic survey reveals

Americans believe cancer to be major health care challenge, Mayo Clinic survey reveals

While Zika remains a hot topic in the news, a new survey by Mayo Clinic reveals that Americans believe the country's most significant health care challenge is cancer. [More]
Majority of cancers can be caused by infectious agents in sub-Saharan Africa, reveals study

Majority of cancers can be caused by infectious agents in sub-Saharan Africa, reveals study

In 1963, Irish surgeon Denis Parson Burkitt airmailed samples of an unusual jaw tumor found in Ugandan children to his colleague, Anthony Epstein, at Middlesex Hospital in London. [More]
Many parents support HPV vaccine school-entry requirements with opt-out provisions

Many parents support HPV vaccine school-entry requirements with opt-out provisions

Requiring students to get vaccinated against the human papillomavirus, or HPV, to enter school could prevent many cancers linked to the virus, but University of North Carolina at Chapel Hill researchers found that many parents only support such requirements with opt-out provisions that could make the laws less effective. [More]
Fruit fly models may help scientists understand underlying mechanism of HPV-induced cancer

Fruit fly models may help scientists understand underlying mechanism of HPV-induced cancer

Human papillomavirus (HPV) is one of the most common sexually transmitted infections in the United States and has been identified as a primary cause of cervical cancer in women. [More]
Pap tests may be beneficial for preventing cervical cancer in older women

Pap tests may be beneficial for preventing cervical cancer in older women

A new study from the University of Illinois confirms a link between Pap smear screenings and a lower risk of developing cervical cancer in women over age 65. However, most American health guidelines discourage women in that age range from receiving screenings unless they have pre-existing risk factors. [More]
FDA approves Roche cobas HPV Test to be used with SurePath Preservative Fluid

FDA approves Roche cobas HPV Test to be used with SurePath Preservative Fluid

The U.S. Food and Drug Administration today approved the Roche cobas HPV Test as the first test for Human Papilloma Virus (HPV) that can be used with cervical cells obtained for a Pap test and collected in SurePath Preservative Fluid. [More]
Routine Pap smear screenings linked to lower cervical cancer risk in older women

Routine Pap smear screenings linked to lower cervical cancer risk in older women

A new study from the University of Illinois confirms a link between routine Pap smear screenings and a lower risk of developing cervical cancer in women over age 65. [More]
Roche Diagnostics responds to HPV announcement

Roche Diagnostics responds to HPV announcement

Roche Diagnostics welcomes the announcement by Public Health Minister, Jane Ellison, to introduce Human Papillomavirus (HPV) primary screening in England. [More]
Unwelcoming healthcare environments may affect cervical cancer screening among LGBT people

Unwelcoming healthcare environments may affect cervical cancer screening among LGBT people

A new study found that certain factors affect cervical cancer screening among lesbian and bisexual women and transgender men. Some of these factors overlap with the general female population, whereas others are specific to the lesbian, bisexual, or queer identity. [More]
Study shows women with CIN3 more likely to develop anogenital cancers

Study shows women with CIN3 more likely to develop anogenital cancers

Women with a history of severe cervical intraepithelial neoplasia, a precancerous condition of the cervix that arises from infection with the human papillomavirus (HPV), had a long-term increased risk of developing anal, vulvar, and vaginal cancer. [More]
QIAGEN announces launch of QIAsure Methylation Test to detect cervical cancer risk

QIAGEN announces launch of QIAsure Methylation Test to detect cervical cancer risk

QIAGEN N.V. today announced the launch of the QIAsure Methylation Test, a novel CE-marked molecular diagnostic test for use in differentiating patients' risk of developing cervical cancer. [More]
Women with SLE may have increased cervical cancer risk

Women with SLE may have increased cervical cancer risk

The results of a study presented today at the European League Against Rheumatism Annual Congress found a doubled risk of pre-malignant cervical changes, and potentially also an increased risk of cervical cancer, among women with Systemic Lupus Erythematosus (SLE) compared to the general female population. [More]
UCLA scientists discover cystatin E/M protein that can inhibit cervical cancer growth

UCLA scientists discover cystatin E/M protein that can inhibit cervical cancer growth

UCLA scientists have identified a protein that has the potential to prevent the growth of cervical cancer cells. The discovery could lead to the development of new treatments for the deadly disease. [More]
Women's group lobbies lawmakers to fund Illinois Breast and Cervical Cancer Program

Women's group lobbies lawmakers to fund Illinois Breast and Cervical Cancer Program

On May 12th, the Metropolitan Chicago Breast Cancer Task Force traveled to Springfield, Illinois to lobby lawmakers to fully fund the Illinois Breast and Cervical Cancer Program, which provides free mammograms and Pap testing for uninsured women aged 35 to 64. [More]
Exercise may significantly lessen cervical cancer risk in women

Exercise may significantly lessen cervical cancer risk in women

Even 30 minutes of exercise per week has the potential to significantly reduce a woman's risk of developing cervical cancer, according to a study from scientists at Roswell Park Cancer Institute (RPCI). The case-control study was recently published in the Journal of Lower Genital Tract Disease. [More]
Scottish women with metastatic carcinoma of cervix could now benefit from Avastin treatment

Scottish women with metastatic carcinoma of cervix could now benefit from Avastin treatment

From today, women in Scotland with an advanced and incurable form of cervical cancer could benefit from the targeted treatment Avastin, which has been given the green light by the Scottish Medicines Consortium (SMC) for routine use on the NHS. [More]
Sexually-assaulted women more likely to develop variety of medical conditions

Sexually-assaulted women more likely to develop variety of medical conditions

Researchers have found that a variety of conditions are more common in women before and after sexual assault. [More]
Combination of two diagnostic tests can decrease chance of missing tumors by sevenfold

Combination of two diagnostic tests can decrease chance of missing tumors by sevenfold

Cytopathology researchers at Houston Methodist Hospital recently found that combining two diagnostic tests, Pap and high-risk human papillomavirus (hrHPV), dramatically decreased the chance of missing tumors and high-grade lesions by sevenfold. [More]
Advertisement
Advertisement